V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013531 | 270014274 | 1.64 | 65.4 | Palliative (P) | 2013-06-19 | 2013-07-19 | Cetuximab + FOLFIRI cycle1 | N | N | 270015090 | CETUXIMAB + IRINOTECAN + MDG |
| 270013532 | 270019160 | 1.64 | 69.3 | Curative (C) | 2015-02-17 | 2015-02-21 | OEPA | 02 | N | 270015095 | OEPA |
| 270013533 | 270019160 | 1.53 | 50.4 | Palliative (P) | 2018-02-12 | 2018-03-20 | Cetuximab + FLUOROURACIL + IRINOTECAN | N | N | 270015095 | CETUXIMAB + IRINOTECAN + MDG |
| 270013534 | 270019160 | 1.6 | 67.5 | Curative (C) | null | 2014-09-13 | ESHAP | N | null | 270015095 | ESHAP |
| 270013535 | 270009135 | 1.62 | 92 | Curative (C) | 2015-05-14 | 2015-10-08 | ESHAP | N | null | 270015100 | ESHAP |
| 270013536 | 270009135 | 1.79 | 97 | Curative (C) | 2016-05-17 | 2016-05-25 | OEPA | N | N | 270015100 | OEPA |
| 270013537 | 270014276 | 1.83 | 92.9 | Curative (C) | 2015-02-05 | 2016-08-31 | BEAM | N | N | 270015105 | BEAM |
| 270013538 | 270014276 | 1.84 | 60 | Curative (C) | 2015-07-30 | 2015-09-15 | ESHAP | N | Y | 270015105 | ESHAP |
| 270013539 | 270014277 | 1.92 | 32.6 | Disease modification (D) | 2017-07-27 | 2017-08-01 | BEAM | N | null | 270015112 | BEAM |
| 270013540 | 270014277 | 1.46 | 29 | Disease modification (D) | 2018-02-24 | 2018-02-24 | BEAM | N | N | 270015112 | BEAM |
| 270013541 | 270014277 | 1.63 | null | Neo-adjuvant (N) | 2018-09-04 | 2018-09-07 | Cetuximab + FOLFIRI cycle1 | null | null | 270015112 | CETUXIMAB + IRINOTECAN + MDG |
| 270013542 | 270009143 | 1.68 | 67.6 | Curative (C) | 2015-11-09 | 2015-12-08 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 270015115 | CISPLATIN + RT |
| 270013543 | 270009143 | 1.65 | 73.45 | Neo-adjuvant (N) | 2017-04-18 | 2017-04-21 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270015115 | CETUXIMAB + IRINOTECAN + MDG |
| 270013544 | 270019919 | 1.88 | 75 | Neo-adjuvant (N) | 2017-06-14 | 2017-06-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | 270015118 | CETUXIMAB + IRINOTECAN + MDG |
| 270013545 | 270009144 | 1.72 | 90 | null | 2014-08-02 | 2014-11-16 | LEAM | 2 | N | 270015123 | LEAM |
| 270013546 | 270009146 | 1.74 | 51 | Curative (C) | 2017-12-19 | 2017-12-20 | LEAM | 2 | N | 270015123 | LEAM |
| 270013547 | 270009146 | 1.75 | null | Curative (C) | 2014-03-11 | 2014-03-13 | Rituximab | N | N | 270015123 | RITUXIMAB |
| 270013548 | 270014280 | null | 67.95 | Disease modification (D) | 2013-10-20 | 2013-11-02 | BMT BEAM | 02 | N | 270015126 | BEAM |
| 270013549 | 270018316 | 1.61 | 53.9 | Curative (C) | 2013-05-23 | 2013-08-02 | Rituximab | 2 | N | 270015130 | RITUXIMAB |
| 270013550 | 270018316 | 1.59 | 71.9 | null | 2018-01-29 | 2018-01-29 | CETUXIMAB + IRINOTECAN + MDG | null | N | 270015130 | CETUXIMAB + IRINOTECAN + MDG |
| 270013551 | 270014282 | 1.66 | 88.9 | Disease modification (D) | 2017-07-27 | 2017-12-22 | Rituximab | N | N | 270015132 | RITUXIMAB |
| 270013552 | 270009154 | 1.77 | 72 | Curative (C) | 2016-06-12 | 2017-01-11 | ESHAP | 2 | N | 270015133 | ESHAP |
| 270013554 | 270009158 | 1.66 | 78.3 | null | 2017-11-01 | 2017-11-01 | CISPLATIN + RT | N | N | 270015135 | CISPLATIN + RT |
| 270013555 | 270014284 | 1.62 | 62.5 | null | 2015-07-28 | 2015-07-30 | BEAM | 02 | N | 270015138 | BEAM |
| 270013556 | 270016838 | 1.29 | 66.9 | Palliative (P) | null | 2015-01-08 | CETUXIMAB + IRINOTECAN + MDG | null | Y | 270015139 | CETUXIMAB + IRINOTECAN + MDG |
| 270013557 | 270016838 | 1.73 | 129.8 | null | 2017-11-08 | 2017-11-08 | LEAM | N | null | 270015139 | LEAM |
| 270013558 | 270019920 | 1.54 | 69 | Curative (C) | 2013-11-25 | 2013-12-04 | BEAM | N | N | 270015143 | BEAM |
| 270013559 | 270020071 | null | 29 | Neo-adjuvant (N) | null | 2017-02-23 | OEPA | N | N | 270015145 | OEPA |
| 270013560 | 270009160 | 1.75 | 85 | Curative (C) | 2013-11-21 | 2013-11-23 | Cisplatin + Radiotherapy | N | N | 270015146 | CISPLATIN + RT |
| 270013561 | 270009160 | 1.7 | null | Neo-adjuvant (N) | 2017-05-12 | 2018-07-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270015146 | CETUXIMAB + IRINOTECAN + MDG |
| 270013562 | 270009160 | 1.72 | 58.9 | Curative (C) | 2017-05-02 | 2017-05-10 | ESHAP | N | N | 270015146 | ESHAP |
| 270013563 | 270009160 | null | 76.9 | Neo-adjuvant (N) | 2013-07-16 | 2013-07-21 | Cisplatin + Radiotherapy | N | N | 270015146 | CISPLATIN + RT |
| 270013564 | 270020202 | null | 76.5 | null | 2013-07-11 | 2013-09-03 | Cisplatin 100 + RT(H&N) 1 day | null | N | 270015172 | CISPLATIN + RT |
| 270013565 | 270020202 | null | 67.8 | null | 2015-11-24 | 2015-11-25 | Cisplatin + Radiotherapy | N | N | 270015172 | CISPLATIN + RT |
| 270013566 | 270020202 | 1.73 | 97 | Disease modification (D) | 2016-10-09 | 2016-10-16 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270015172 | CISPLATIN + RT |
| 270013567 | 270009161 | 1.75 | null | Curative (C) | 2016-12-27 | 2017-03-01 | Cisplatin + Radiotherapy | 2 | N | 270015185 | CISPLATIN + RT |
| 270013568 | 270009161 | 1.8 | null | null | 2016-12-27 | 2017-01-07 | Cetuximab + FOLFIRI cycle1 | N | N | 270015185 | CETUXIMAB + IRINOTECAN + MDG |
| 270013569 | 270009161 | 1.45 | 73.2 | Curative (C) | 2017-10-17 | 2017-10-28 | OEPA | 02 | N | 270015185 | OEPA |
| 270013570 | 270009164 | 1.81 | 89.8 | Curative (C) | 2015-10-12 | 2015-11-12 | Cisplatin + Radiotherapy | N | N | 270015193 | CISPLATIN + RT |
| 270013571 | 270016841 | 1.39 | 73.4 | Curative (C) | 2017-10-26 | 2017-10-26 | Cisplatin 100 + RT(H&N) 1 day | 2 | Y | 270015194 | CISPLATIN + RT |
| 270013572 | 270009165 | 1.38 | 62.9 | Curative (C) | 2014-11-02 | 2014-12-01 | Rituximab | N | N | 270015197 | RITUXIMAB |
| 270013573 | 270009166 | 1.81 | null | Curative (C) | 2015-01-04 | 2015-01-29 | OEPA | N | null | 270015197 | OEPA |
| 270013574 | 270009167 | 1.92 | 61 | null | 2016-02-17 | 2016-02-17 | LEAM | N | N | 270015198 | LEAM |
| 270013575 | 270009169 | 1.7 | 71 | Curative (C) | 2014-01-17 | 2014-01-19 | LEAM | N | N | 270015201 | LEAM |
| 270013576 | 270009169 | 1.63 | 94.2 | Neo-adjuvant (N) | 2016-10-23 | 2017-01-02 | Cisplatin + Radiotherapy | N | N | 270015201 | CISPLATIN + RT |
| 270013577 | 270009170 | 1.73 | 68.9 | Curative (C) | 2017-04-02 | 2017-04-08 | BEAM | null | N | 270015205 | BEAM |
| 270013578 | 270009171 | 1.58 | null | Curative (C) | 2016-01-18 | 2016-01-18 | ESHAP | N | N | 270015207 | ESHAP |
| 270013579 | 270009173 | 1.87 | 69 | Curative (C) | 2016-06-30 | 2016-06-30 | LEAM | 02 | N | 270015209 | LEAM |
| 270013580 | 270014292 | 1.58 | null | Curative (C) | 2014-11-14 | 2014-11-19 | CISPLATIN + RT | N | null | 270015209 | CISPLATIN + RT |
| 270013581 | 270009174 | 1.52 | 66.6 | Neo-adjuvant (N) | 2017-02-22 | 2017-02-23 | OEPA | N | N | 270015214 | OEPA |